Stage
No active trials
Next date
None yet
Trials
0 active
1 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Iron Deficiency Anemia
- Main trialPhase 2
- “The purpose is to evaluate the efficacy and safety of IOP Injection (MPB-1514) for the treatment of iron-deficient anemia (IDA).”In the company’s words, NCT03485053 on ClinicalTrials.gov
Other drugs for Iron Deficiency Anemia
- Ferric BepectateAFT Pharmaceuticals, Ltd. · Phase 3
- SutacimigHemab ApS · Phase 3
- FerumoxytolAMAG Pharmaceuticals, Inc. · Phase 3
- Ferric derisomaltoseSichuan Huiyu Pharmaceutical Co., Ltd · Phase 1
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Terminated | 30 Sep 2020 | A Single Ascending Study of IOP Injection in Patients With Iron Deficient Anemia |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026